BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12766804)

  • 1. Conditional gene activation in cultured hepatocytes using a ligand-dependent chimeric Cre recombinase.
    Zhu HZ; Cao YY; Cheng GX; Xue JL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 May; 35(5):435-40. PubMed ID: 12766804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver.
    Tannour-Louet M; Porteu A; Vaulont S; Kahn A; Vasseur-Cognet M
    Hepatology; 2002 May; 35(5):1072-81. PubMed ID: 11981757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A transgenic mouse that targets the expression of Cre recombinase in hepatocyte].
    Wang YL; Cheng X; Cui F; Cheng J; Lü YX; Yang X
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):163-6. PubMed ID: 15059303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse alpha1(I)-collagen promoter is the best known promoter to drive efficient Cre recombinase expression in osteoblast.
    Dacquin R; Starbuck M; Schinke T; Karsenty G
    Dev Dyn; 2002 Jun; 224(2):245-51. PubMed ID: 12112477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
    Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
    Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
    Hayashi S; McMahon AP
    Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells.
    Lantinga-van Leeuwen IS; Leonhard WN; van de Wal A; Breuning MH; Verbeek S; de Heer E; Peters DJ
    Genesis; 2006 May; 44(5):225-32. PubMed ID: 16652363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
    Jäger R; Maurer J; Jacob A; Schorle H
    Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice engineered to target Cre/loxP-mediated DNA recombination into catecholaminergic neurons.
    Gelman DM; Noaín D; Avale ME; Otero V; Low MJ; Rubinstein M
    Genesis; 2003 Aug; 36(4):196-202. PubMed ID: 12929090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient in vitro and in vivo excision of floxed sequences with a high-capacity adenoviral vector expressing Cre recombinase.
    Badorf M; Edenhofer F; Dries V; Kochanek S; Schiedner G
    Genesis; 2002 Jul; 33(3):119-24. PubMed ID: 12124944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Odontoblast-specific expression of cre recombinase successfully deletes gene segments flanked by loxP sites in mouse teeth.
    Sreenath TL; Cho A; Thyagarajan T; Kulkarni AB
    Genesis; 2003 Feb; 35(2):94-9. PubMed ID: 12533791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte cell-specific expression of doxycycline inducible Cre recombinase in mice.
    Juhila J; Roozendaal R; Lassila M; Verbeek SJ; Holthofer H
    J Am Soc Nephrol; 2006 Mar; 17(3):648-54. PubMed ID: 16467448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Z/AP, a double reporter for cre-mediated recombination.
    Lobe CG; Koop KE; Kreppner W; Lomeli H; Gertsenstein M; Nagy A
    Dev Biol; 1999 Apr; 208(2):281-92. PubMed ID: 10191045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional gene modification in mouse liver using hydrodynamic delivery of plasmid DNA encoding Cre recombinase.
    Zhu HZ; Wang W; Feng DM; Sai Y; Xue JL
    FEBS Lett; 2006 Aug; 580(18):4346-52. PubMed ID: 16846600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.